Processa Pharmaceuticals (PCSA) vs Scienture (SCNX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Processa Pharmaceuticals is the larger company by market cap ($4.4 million vs $4.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PCSA | SCNX |
|---|---|---|
| Share price | $1.56 | $2.28 |
| Market cap | $4.37M | $4.07M |
| 1-day change | -7.69% | -6.45% |
| EPS (TTM) | $-68.29 | $-51.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $431.61K |
| Revenue growth (YoY) | — | +215.87% |
| Net income (latest FY) | $-13.56M | $-41.51M |
| Gross margin | — | 76.80% |
| Operating margin | — | -9867.92% |
| Net margin | — | -9618.03% |
| 52-week high | $8.88 | $18.75 |
| 52-week low | $1.04 | $2.00 |
| Distance from 52-week high | -82.43% | -87.85% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +1546.25% |
| Average volume | 79.50K | 156.51K |
| Shares outstanding | 2.80M | 1.79M |
| Employees | 12 | 4 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Processa Pharmaceuticals
PCSA stock →Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells.
Health Care · Biotechnology: Pharmaceutical Preparations · 12 employees
About Scienture
SCNX stock →Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
PCSA vs SCNX FAQ
Which is bigger, Processa Pharmaceuticals or Scienture?
Processa Pharmaceuticals (PCSA) is larger, with a market capitalization of $4.37M compared with $4.07M for Scienture (SCNX).
Are Processa Pharmaceuticals and Scienture in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.